In Vitro Synergy Testing of Eravacycline in Combination with Clarithromycin and Rifabutin against Mycobacterium abscessus Complex

In Vitro Synergy Testing of Eravacycline in Combination with Clarithromycin and Rifabutin against Mycobacterium abscessus Complex

Bibliographic Details
Main Authors:	Ka Lip Chew, Sophie Octavia, Siang Fei Yeoh, Jeanette W. P. Teo
Format:	Article
Language:	English
Published:	American Society for Microbiology 2021-09-01
Series:	Microbiology Spectrum
Subjects:	checkerboard broth microdilution clofazimine eravacycline Mycobacterium abscessus complex rifabutin synergy
Online Access:	https://journals.asm.org/doi/10.1128/Spectrum.00045-21

Similar Items

Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro
by: Anqi Li, et al.
Published: (2023-06-01)

Teicoplanin – Tigecycline Combination Shows Synergy Against Mycobacterium abscessus
by: Dinah B. Aziz, et al.
Published: (2018-05-01)

Rifabutin Suppresses Inducible Clarithromycin Resistance in <i>Mycobacterium abscessus</i> by Blocking Induction of <i>whiB7</i> and <i>erm41</i>
by: Dinah Binte Aziz, et al.
Published: (2020-02-01)

Mycobacterium abscessus skin and soft tissue infection following autologous fat grafting in Kurdistan treated with an antibiotic combination including Imipenem-Relebactam and Rifabutin
by: Alison J. Beech, et al.
Published: (2023-08-01)

Rifabutin: A Repurposing Candidate for Mycobacterium abscessus Lung Disease
by: Thomas Dick, et al.
Published: (2020-02-01)

Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of M. abscessus lung disease
by: Elisa H. Ignatius, et al.
Published: (2024-07-01)

Synergism of eravacycline combined with other antimicrobial agents against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii
by: Yun Li, et al.
Published: (2022-09-01)

Clofazimine susceptibility testing of Mycobacterium avium complex and Mycobacterium abscessus: a meta-analysis study
by: Bahareh Hajikhani, et al.
Published: (2021-09-01)

Comparison of broth microdilution, broth disk elution and automated system results in determining vancomycin susceptibilities of Staphylococcus aureus strains
by: Tuğba Ayvalık, et al.
Published: (2024-12-01)

Secondary spontaneous pneumothorax in a patient with resistant Mycobacterium abscessus infection and systemic sclerosis-associated interstitial lung disease: A case report
by: Yoko Nishizawa, et al.
Published: (2023-01-01)

Ascorbigen — Rifabutin Toxicity Modifier
by: E. R. Pereverzeva, et al.
Published: (2020-12-01)

Review of Colistin Susceptibility Testing with Current Data
by: Yasemin NADİR, et al.
Published: (2024-05-01)

CRISPR Interference-Based Inhibition of MAB_0055c Expression Alters Drug Sensitivity in Mycobacterium abscessus
by: Thanh Quang Nguyen, et al.
Published: (2023-06-01)

Omadacycline for the treatment of Mycobacterium abscessus infections: Case series and review of the literature
by: Ayesha Siddiqa, et al.
Published: (2023-01-01)

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
by: Carolina Arana Stanis Schmaltz, et al.
Published: (2019-02-01)

In vitro susceptibility of common Enterobacterales to eravacycline in Taiwan
by: Chun-Fu Huang, et al.
Published: (2023-04-01)

Efficacy and safety of eravacycline: A meta-analysis
by: Khalid Eljaaly, et al.
Published: (2021-03-01)

Comparison of Broth Microdilution and Colistin Disk Elution Methods for the Determination of Colistin Susceptibility in Multidrug Resistant Pseudomonas aeruginosa Isolates
by: Neslihan ARICI, et al.
Published: (2023-08-01)

Development of a Broth Microdilution Method To Characterize Chlorhexidine MICs among Bacteria Collected from 2005 to 2019 at Three U.S. Sites
by: Joseph D. Lutgring, et al.
Published: (2023-06-01)

A retrospective, multicentre evaluation of eravacycline utilisation in community and academic hospitals
by: Athena L.V. Hobbs, et al.
Published: (2022-06-01)

Spherical amorphous nanoparticles loading with antituberculosis substance rifabutin
by: A. P. Kaplun, et al.
Published: (2010-04-01)

Unusually high clarithromycin resistance in Mycobacterium abscessus subsp. abscessus isolated from human gastric epithelium
by: Deepak Chouhan, et al.
Published: (2023-08-01)

Exploring the Antibiofilm Effect of Sertraline in Synergy with <i>Cinnamomum verum</i> Essential Oil to Counteract <i>Candida</i> Species
by: Alexia Barbarossa, et al.
Published: (2024-08-01)

Analysis of antibiotic sensitivity of clinical strains of microorganisms with the Russian Mueller–Hinton broth
by: Irina S. Kosilova, et al.
Published: (2024-12-01)

Development of Resistance to Eravacycline by Klebsiella pneumoniae and Collateral Sensitivity-Guided Design of Combination Therapies
by: Congjuan Xu, et al.
Published: (2022-10-01)

Antimicrobial activity of eravacycline and other comparative agents on aerobic and anaerobic bacterial pathogens in Taiwan: A clinical microbiological study
by: Ming-Han Tsai, et al.
Published: (2024-06-01)

Determination of Colistin and Tigecycline Resistance Profile of Acinetobacter Baumannii Strains from Different Clinical Samples in a Territory Hospital in Turkey
by: Merih Şimşek, et al.
Published: (2020-03-01)

Skipped wells and scientific error during fosfomycin agar dilution and broth microdilution lead to inconsistent minimal inhibitory concentrations and may be cause for reevaluating testing methods for Klebsiella pneumoniae
by: Morgan L. Bixby, et al.
Published: (2024-08-01)

Comparison of microdilution broth and disk diffusion for antifungal susceptibility testing against Candida spp.<:Comparison of microdilution broth and disk diffusion for antifungal susceptibility testing against Candida spp.<br> Comparação entre microdiluição e disco difusão para o teste de susceptibilidade aos antifúngicos contra Candida spp.
by: Carlla Lorena Façanha Silva, et al.
Published: (2012-06-01)

Investigation of the Antitrichomonal Activity of Cinnamaldehyde, Carvacrol and Thymol and Synergy with Metronidazole
by: Yener Özel, et al.
Published: (2024-06-01)

Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022
by: Ashlan J. Kunz Coyne, et al.
Published: (2024-01-01)

Rifabutin-based Fourth and Fifth-line Rescue Therapy in Patients with for Helicobacter pylori Eradication Failure
by: Jihee Sung, et al.
Published: (2017-02-01)

A Case Series of Rifabutin Use in Staphylococcal Prosthetic Infections
by: Miranda Monk, et al.
Published: (2022-06-01)

Rifabutin-Cobicistat Drug Interaction Resulting in Severe Bilateral Panuveitis
by: Christopher B. Toomey, et al.
Published: (2020-04-01)

Manuka honey in combination with azithromycin shows potential for improved activity against Mycobacterium abscessus
by: Victoria C. Nolan, et al.
Published: (2022-12-01)

rpoB Mutations are Associated with Variable Levels of Rifampin and Rifabutin Resistance in Mycobacterium tuberculosis
by: Li MC, et al.
Published: (2022-11-01)

An Optimized Checkerboard Method for Phage-Antibiotic Synergy Detection
by: Isidora Nikolic, et al.
Published: (2022-07-01)

Segmental retinal arteritis in a case of presumed bilateral rifabutin-associated hypopyon uveitis
by: Shefali Sood, et al.
Published: (2024-12-01)

Tenofovir alafenamide and rifabutin co-administration does not lead to loss of HIV-1 suppression: A retrospective observational study
by: Thomas C.S. Martin, et al.
Published: (2020-11-01)

Pharmacokinetic features of dolutegravir with rifampicin and rifabutin among patients coinfected with human immunodeficiency virus and tuberculosis/mycobacterium avium complex
by: Xiaoqin Le, et al.
Published: (2022-03-01)